The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Optimizing Treatment of Desmoid Tumors
Abstract
Purpose: This study compared a large series of desmoid patients treated at a single institution to a previously published series from the same institution to determine if patient population characteristics, treatment approaches, and clinical outcomes had undergone change over the two study periods. Materials and Methods: Data from a prospective soft tissue tumor database was used to analyze clinical courses of 189 desmoid patients treated at The University of Texas M.D. Anderson Cancer Center (UTMDACC) from 1995 to 2005 as compared with 189 UTMDACC desmoid patients treated between 1965 and 1994. Results: A nearly three-fold increase in annualized UTMDACC desmoid referral volume with significantly higher percentages and numbers of primary desmoid tumor referrals to UTMDACC was observed in the most recent study period. Significantly increased systemic therapy use and decreased reliance on surgery alone was observed more recently. While the recent series patients had higher rates of macroscopic residual disease and equivalent rates of positive microscopic margins after definitive surgery, the estimated 5-year local recurrence rate of 20% was improved compared with the 30% rate observed in the earlier series. Conclusion: Increased awareness of the complex multidisciplinary management needed for desmoid tumor control may underlie significantly increased numbers of referrals to UTMDACC, especially primary untreated desmoids. Increased neoadjuvant treatments may be associated with improved desmoid patient outcomes. These trends should be supported, particularly if personalized molecular-based therapies are to be rapidly and effectively deployed for the benefit of those afflicted by this rare and potentially debilitating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ballo, M. T., Zagars, G. K., Pollack, A., Pisters, P. W. T., & Pollock, R. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.158 · Cited by 501
Self-citationNuyttens, J. J., Rust, P. F., Thomas, C. R., & Turrisi, A. T. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7<1517::aid-cncr3>3.0.co;2-9 · Cited by 487
High‐dose tamoxifen and sulindac as first‐line treatment for desmoid tumors
Hansmann, A., Adolph, C., Vogel, T., Unger, A., & Moeslein, G. (2004) · Cancer · doi:10.1002/cncr.11937 · Cited by 357
Gronchi, A., Casali, P. G., Mariani, L., Lo Vullo, S., Colecchia, M., Lozza, L., Bertulli, R., Fiore, M., Olmi, P., Santinami, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.150 · Cited by 354
The Desmoid Tumor: Not a Benign Disease
Posner, M. C. (1989) · Archives of Surgery · doi:10.1001/archsurg.1989.01410020061010 · Cited by 330
Lewis, J. J., Boland, P. J., Leung, D. H. Y., Woodruff, J. M., & Brennan, M. F. (1999) · Annals of Surgery · doi:10.1097/00000658-199906000-00014 · Cited by 327
Extremity and trunk desmoid tumors: a multifactorial analysis of outcome.
Merchant, N. B., Jl, L., Woodruff, J. M., et al. (1999) · PubMed · Cited by 327
Alman, B. A., Li, C., Pajerski, M. E., Díaz‐Cano, S. J., & Wolfe, H. J. (1997) · Europe PMC (PubMed Central) · Cited by 322
Heinrich, M. C., McArthur, G. A., Demetri, G. D., Joensuu, H., Bono, P., Herrmann, R., Hirte, H., Cresta, S., Koslin, D. B., Corless, C. L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0717 · Cited by 318
Extra-abdominal desmoid tumors.
Rock, M. G., Pritchard, D. J., Reiman, H. M., Soule, E. H., & Brewster, R. C. (1984) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198466090-00007 · Cited by 315
Cheon, S. S., Cheah, A. Y. L., Turley, S., Nadesan, P., Poon, R., Clevers, H., & Alman, B. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102657399 · Cited by 313
Extremity and trunk desmoid tumors: A multifactorial analysis of outcome
Merchant, N. B., Lewis, J. J., Woodruff, J. M., Leung, D. H. Y., & Brennan, M. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991115)86:10<2045::aid-cncr23>3.0.co;2-f · Cited by 280
Individualizing management of aggressive fibromatoses
Spear, M. A., Jennings, L. C., Mankin, H. J., Spiro, I. J., Springfield, D. S., Gebhardt, M. C., Rosenberg, A. E., Efird, J. T., & Suit, H. D. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00845-6 · Cited by 277
Response of extraabdominal desmoid tumors to therapy with imatinib mesylate
Mace, J., Sybil Biermann, J., Sondak, V., McGinn, C., Hayes, C., Thomas, D., & Baker, L. (2002) · Cancer · doi:10.1002/cncr.11029 · Cited by 193
Desmoid fibromatosis is a clonal process
Li, M., Cordon-Cardo, C., Gerald, W. L., & Rosai, J. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90221-x · Cited by 167
Radiation therapy in the management of desmoid tumors
Ballo, M. T., Zagars, G. K., & Pollack, A. S. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00285-5 · Cited by 153
Self-citationAggressive Fibromatosis (Desmoid Tumor) is A Monoclonal Disorder
Alman, B. A., Pajerski, M. E., Díaz‐Cano, S. J., Corboy, K., & Wolfe, H. J. (1997) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199704000-00005 · Cited by 141
Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma.
Gelmann, E. P. (1997) · PubMed · Cited by 93
Cited by
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Gamboa, A. C., Gronchi, A., & Cardona, K. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21605 · Cited by 524
Imatinib: A Breakthrough of Targeted Therapy in Cancer
Iqbal, N., & Iqbal, N. (2014) · Chemotherapy Research and Practice · doi:10.1155/2014/357027 · Cited by 470
Lazar, A. J. F., Tuvin, D., Hajibashi, S., Habeeb, S., Bolshakov, S., Mayordomo-Aranda, E., Warneke, C. L., Lopez-Terrada, D., Pollock, R. E., & Lev, D. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080475 · Cited by 455
Self-citationKasper, B., Baumgarten, C., Garcia, J., Bonvalot, S., Haas, R., Haller, F., Hohenberger, P., Penel, N., Messiou, C., van der Graaf, W. T., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx323 · Cited by 422
Self-citation
Metadata
- Authors
- Lev, D., Kotilingam, D., Wei, C., Ballo, M. T., Zagars, G. K., Pisters, P. W. T., Lazar, A. A., Patel, S. R., Benjamin, R. S., & Pollock, R. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-05-01
- Volume
- 25
- Issue
- 13
- Pages
- 1785-1791
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2110758327
- Cited by
- 280
- References
- 18
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.